The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression.
FSCN1
actin bundle
breast cancer
tumor progression
tumorigenesis
Journal
Yi chuan = Hereditas
ISSN: 0253-9772
Titre abrégé: Yi Chuan
Pays: China
ID NLM: 9436478
Informations de publication
Date de publication:
20 Feb 2023
20 Feb 2023
Historique:
entrez:
17
3
2023
pubmed:
18
3
2023
medline:
21
3
2023
Statut:
ppublish
Résumé
FSCN1, an actin-bundling protein, is highly expressed in almost all metastatic tumors and is associated with the poor prognosis. In breast cancer FSCN1 is highly expressed in basal-like and triple negative subgroups. There is significant progress in understanding the role of fascin in breast cancer. Studies on FSCN1 in recent years have revealed that FSCN1 not only promotes tumor migration, invasion, metastic colonization, cancer cell self-renewal and drug resistance, but also regulates glucose and lipid metabolism and mitochondrial remodeling in tumor cells. In this review, we focus on the structure and regulatory mechanism of FSCN1 in breast tumorigenesis and metastasis, and discuss the clinical value of FSCN1 with the aim to provide a direction for further research in this field. FSCN1是一种肌动蛋白结合蛋白,能够将肌动蛋白丝集成一束。FSCN1在几乎所有的转移性肿瘤中高表达,并与大部分肿瘤的不良预后密切相关。
Autres résumés
Type: Publisher
(chi)
FSCN1是一种肌动蛋白结合蛋白,能够将肌动蛋白丝集成一束。FSCN1在几乎所有的转移性肿瘤中高表达,并与大部分肿瘤的不良预后密切相关。
Identifiants
pubmed: 36927659
pii: 22-346
doi: 10.16288/j.yczz.22-346
doi:
Substances chimiques
FSCN1 protein, human
0
Carrier Proteins
0
Microfilament Proteins
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM